Skip to main content
SpringerLink
Log in

Precision Medicine in the Intensive Care Unit: Identifying Opportunities and Overcoming Barriers

  • Chapter
  • First Online:
Annual Update in Intensive Care and Emergency Medicine 2019

Part of the book series: Annual Update in Intensive Care and Emergency Medicine ((AUICEM))

  • 1721 Accesses

Abstract

Is precision medicine really precise? Precision in medicine can only be achieved with precision diagnostics. Unfortunately, barriers such as access to clean electronic medical data, accurate and precise laboratory tests, and a propensity to over simplify complex pathophysiology hinders this transformation to achieve the ‘four Ps’ of precision medicine: Personalized, Preventive, Predictive, and Participatory.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sugeir S, Naylor S. Critical care and personalized or precision medicine: who needs whom? J Crit Care. 2018;43:401–5.

    Article  Google Scholar 

  2. Naylor S. What’s in a name? The evolution of “P-medicine”. J Precision Med. 2015;2:15–29.

    Google Scholar 

  3. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–5.

    Article  CAS  Google Scholar 

  4. Vincent J. The coming era of precision medicine for intensive care. Crit Care. 2017;21(Suppl 3):314.

    Article  Google Scholar 

  5. Redekop WK, Madsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16:S4–9.

    Article  Google Scholar 

  6. Zhang XD. Precision medicine, personalized medicine, omics, and big data: concepts and relationships. J Pharmacogenomics Pharmacoproteomics. 2015;6:e14.

    Google Scholar 

  7. Wong HR. Intensive care medicine in 2050: precision medicine. Intensive Care Med. 2017;43:1507–9.

    Article  Google Scholar 

  8. Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinic-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra95.

    Article  Google Scholar 

  9. Aung AK, Haas DW, Hulgan T, Phillips EJ. Pharmacogenomics of antimicrobial agents. Pharmacogenomics. 2014;15:1903–30.

    Article  CAS  Google Scholar 

  10. Sweeney TE, Khatri P. Generalizable biomarkers in critical care: toward precision medicine. Crit Care Med. 2017;45:934–9.

    Article  Google Scholar 

  11. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.

    Article  Google Scholar 

  12. McMahon BA, Koyner JL. Risk stratification for acute kidney injury: are biomarkers enough? Adv Chronic Kidney Dis. 2016;23:167–78.

    Article  Google Scholar 

  13. Ridenour RV, Gada RP, Brost BC, Karon BS. Comparison of lactate values between point-of-care and central laboratory analyzers. Am J Clin Pathol. 2007;128:168–71.

    Article  Google Scholar 

  14. Apple FS. Counterpoint: standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem. 2011;58:169–71.

    Article  Google Scholar 

  15. Christenson RH, Bunk DM, Schimmel H, et al. Point; Put simply, standardization of cardiac troponin I is complicated. Clin Chem. 2012;58:165–8.

    Article  CAS  Google Scholar 

  16. Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem. 2008;45:349–55.

    Article  CAS  Google Scholar 

  17. Kost GJ, Tran NK, Louie RF, et al. Assessing the performance of handheld glucose testing for critical care. Diabetes Technol Ther. 2008;10:445–51.

    Article  CAS  Google Scholar 

  18. Moss DW, Baron DN, Walker PG, et al. Standardization of clinical enzyme assays. J Clin Pathol. 1971;24:740–3.

    Article  CAS  Google Scholar 

  19. Pieroini L, Bargnoux AS, Cristl JP, et al. Did creatinine standardization give benefits to the evaluation of glomerular filtration rate. EJIFCC. 2017;28:251–7.

    Google Scholar 

  20. Poller L. International normalized ratios (INR): the first 20 years. J Thromb Haemost. 2004;2:849–60.

    Article  CAS  Google Scholar 

  21. Tolan NV, Wockenfus AM, Koch CD, et al. Analytical performance of three whole blood point-of-care lactate devices compared to plasma lactate comparison methods sand a flow-injection mass spectrometry method. Clin Biochem. 2017;50:168–73.

    Article  CAS  Google Scholar 

  22. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trial. Lancet Respir Med. 2014;2:611–20.

    Article  Google Scholar 

  23. Famous KR, Delucchi K, Ware LB, et al. ARDS subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2016;195:331–8.

    Article  Google Scholar 

  24. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–17.

    Article  CAS  Google Scholar 

  25. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.

    Article  Google Scholar 

  26. Investigators TNICE-SUGARS. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.

    Article  Google Scholar 

  27. Ceriotti F, Kaczmarek E, Guerra E, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9:268–77.

    Article  Google Scholar 

  28. Belard A, Buchman T, Dente CJ, Potter BK, Kirk A, Elster E. The Uniformed Services University’s Surgical critical Care Initiative (SC2I): bringing precision medicine to the critically ill. Mil Med. 2018;183:487–95.

    Article  Google Scholar 

  29. Lima K, Caynak R, Tran NK. Lactate monitoring for severe sepsis and septic shock: are all lactate measurements the same? Crit Care Med. 2016;44:443.

    Article  Google Scholar 

  30. Empey PE, Miller TM, Philbrick AH, et al. Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest. Crit Care Med. 2012;40:1221–8.

    Article  CAS  Google Scholar 

  31. Udy AA, Roberts JA, Lipman J, Blot S. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: an appraisal utilizing antibiotics. Adv Drug Deliv Rev. 2017;123:65–74.

    Article  Google Scholar 

  32. Godwin Z, Lima K, Greenhalgh D, Palmieri T, Sen S, Tran NK. A retrospective analysis of clinical laboratory interferences caused by frequently administered medications in burn patients. J Burn Care Res. 2016;37:10–7.

    Article  Google Scholar 

  33. Lauer MS, D’Agostina RB. The randomized registry trial-the next disruptive technology in clinical research? N Engl J Med. 2013;369:1579–81.

    Article  CAS  Google Scholar 

  34. Maslove DM, Lamontagne F, Marshall JC, Heyland KD. A path to precision in the ICU. Crit Care. 2017;21:79–88.

    Article  Google Scholar 

  35. Noy NF, Shah NH, Whetzel PL, et al. BioPortal: ontologies and integrated data resources at the click of a mouse. Nucleic Acids Res. 2009;37:170–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Firefighters Burn Institute, Burn Center at the University of California, Davis, CA, USA

    T. L. Palmieri

  2. Burns Department, Shriners Hospitals for Children Northern California, Sacramento, CA, USA

    T. L. Palmieri

  3. Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Davis, CA, USA

    N. K. Tran

Authors
  1. T. L. Palmieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. K. Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. L. Palmieri .

Editor information

Editors and Affiliations

  1. Dept. of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium

    Jean-Louis Vincent

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Palmieri, T.L., Tran, N.K. (2019). Precision Medicine in the Intensive Care Unit: Identifying Opportunities and Overcoming Barriers. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2019. Annual Update in Intensive Care and Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-06067-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-06067-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-06066-4

  • Online ISBN: 978-3-030-06067-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation